No more chemotherapy for certain cancer! - healthprevention.ch
 
Geneva:
+4122 840 33 34
 
Moscow:
+7(903)720 80 57
 
No more chemotherapy for certain cancer!

This is a breakthrough: many patients with breast or lung cancer can avoid chemotherapy and its serious side effects, according to studies  that should change the way cancers are treated.

The first good news is for women who have had breast cancer. Up to 70% of them can avoid chemotherapy, depending on the results of an existing genetic test, and be treated with hormonal drugs usually prescribed after an operation to remove the tumor.

Tumor analyzed genetically

As for lung cancer, studies also presented at the big annual cancer conference in Chicago (ASCO) show a new era where patients will see their tumors analyzed genetically. If certain mutations are detected, a tumor-specific drug may be prescribed.

Otherwise, in most cases, the patient will be able to receive a new type of treatment, such as immunotherapy. The majority of patients would therefore avoid nausea, hair loss and other side effects caused by highly toxic chemotherapy.

Thanks to a succession of clinical trials, the entire lung cancer treatment model has been turned upside down, an “extraordinary” change, according to a specialist.

Breast cancer

Currently, many women undergo chemotherapy after the surgical removal of the tumor, in addition to hormone therapy drugs, to prevent the eventual return of cancer.

But an international study on 10,000 women concluded that the level justifying the use of chemotherapy could be revised safely. For years, a genetic test performed on the tumor has predicted the probability of recurrence. This test gives a score between 0 and 100. Until now, chemotherapy was recommended above 25. Below 10, it was not. This posed a dilemma for women in the gray zone, between 11 and 25.

The study showed that for these women, after nine years of follow-up, chemotherapy did not bring anything.

Lung cancer

For the most common type of lung cancer, it is immunotherapy that offers huge hope. Pharmaceutical companies are competing fiercely in this field.

At the conference, a study on the Keytruda, or pembrolizumab made big noise. The American company Merck, known as MSD abroad, has bet everything on it. It is taken intravenously, every three weeks, and has become the best-seller of the laboratory, especially against melanoma and lung cancer.

Immunotherapy drugs help the patient’s immune system do what it is supposed to do: detect and attack the tumor. The method does not work against all types of cancers and can cause serious side effects, sometimes to the point where patients stop treatment.

For the latest clinical trial, funded by MSD, the researchers compared the efficacy of taking Keytruda alone to chemotherapy (the effect of the combination of the two protocols was studied separately, and shows good results in some cases) . Patients first treated with pembrolizumab lived four to eight months longer than those who received only chemotherapy. Above all, they were less likely to suffer serious side effects (18% versus 41%).

 

Comments
Articles
Patient registration form
Topics
Examination Incorpore
nutrition
oncology
prevention
dermatology
cancer
Anti-aging
age management
detoxification
skin
diagnosis
heavy metal
cardiology
immunology
liver detox
oncology treatment
DNA
pain
Genetics
stem cells
allergy
Fertility
weight management
infertility
weight loss
liver
cosmetology
gastroenterology
Sleep
gynecology
Examination partner centres
rehabilitation
chelation
obstetrics
pregnancy
headache
check-up
anti-aging
candida
radiology
immune system
neurology
urology
arsenic
breast cancer
immunotherapy
probiotics
NAD+
mesotherapy
Apnea
tinnitus
Дерматология
joints
Hepatitis C
heart MRI
covid19
Blood pressure
skincare
ulcer
research
abdominal pain
sugar
menopause
migraine
beau-rivage
hyaluronic acid
Allergology
pancreas
gastritis
flu vaccine
gastroscopy
rhesus factor
preventiion
brain surgery awake
andropause
sexuality
obstertics
PRP
light therapy
nutrigenomics
excimer laser
psoriasis
regeneration
telomere
mastectomy
narcosis
hand
shoulder
intestinal flora
depression
second opinion
iron
Omega-3
R-loops
cellmen
mammography
cellcosmet
herniated disc
magnesium
flu
reflexology
vitamin K
exercise
beauty
sports
cholesterol
Treatment programs
stress
knee
hip
vitamin b12
food
mercury
water
back pain
erectile dysfunction
food intolerances
diabetes
acne
endometriosis
LED therapy
biopsy
oral checkup
liquid biopsy
blood test
reconstruction
acnea
digestion
migraines
chronic headaches
oncoloy
diet
dermatitis
endocrinology
rheumatology
pomegranate
orthopedics
colonoscopy
propofole
cellulite
proctology
pneumology
general surgery
hormones
nephrology
kidney
lungs
plastic surgery
ophthalmology